
Aspen Aerogels Hits 52-Week Low of $3.70 Amidst Major Decline
2025-11-10 17:08:18Aspen Aerogels, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 87.69% decline in stock price. The company reported a significant drop in operating profit and has experienced six consecutive quarters of negative results, raising concerns about its financial health and market position.
Read More
Aspen Aerogels Hits 52-Week Low at $4.08 Amidst Significant Decline
2025-11-07 16:01:25Aspen Aerogels, Inc. has reached a new 52-week low, reflecting a challenging year with an 86.89% decline in performance. The company reported a significant drop in both pre-tax and net profits, alongside low return on equity and a market capitalization of USD 557 million, indicating ongoing financial struggles.
Read More
Aspen Aerogels Forms Golden Cross, Signaling Potential Bullish Breakout
2025-10-30 15:33:55Aspen Aerogels, Inc. has recently experienced a Golden Cross, indicating a potential shift in momentum. The stock shows a daily bullish trend in moving averages, suggesting increased investor interest. Despite a significant decline over the past year, recent short-term performance has shown signs of resilience.
Read MoreIs Aspen Aerogels, Inc. technically bullish or bearish?
2025-09-20 19:28:17As of 12 September 2025, the technical trend for Aspen Aerogels, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the daily moving averages being bearish and the monthly MACD also showing a bearish signal. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish indicators. The stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -41.25% versus the S&P 500's 12.22%, and a one-year return of -71.95% compared to 17.14% for the benchmark....
Read MoreIs Aspen Aerogels, Inc. overvalued or undervalued?
2025-09-20 18:04:23As of 8 May 2025, the valuation grade for Aspen Aerogels, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, as evidenced by its P/E ratio of 13, which is significantly lower than the peer average of 29.81 for Montauk Renewables, Inc. Additionally, Aspen's EV to EBITDA ratio stands at 6.03, while its peers show higher valuations, further supporting the notion of overvaluation. The PEG ratio of 0.06 also suggests that the stock may not be justified at its current price. In comparison to its peers, Montauk Renewables, Inc. has a P/E of 50.38, indicating a much higher market valuation relative to earnings, while Enviva, Inc. is also struggling with a risky valuation. Over the past year, Aspen Aerogels has seen a return of -71.95%, starkly contrasting with the S&P 500's return of 17.14%, highlighting the company's ...
Read More
Aspen Aerogels, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
2025-09-16 18:39:28Aspen Aerogels, Inc. has recently revised its evaluation amid challenging market conditions, with its stock priced at $6.71. Over the past year, the company has experienced a significant decline of nearly 73%, contrasting sharply with the S&P 500's positive performance. Technical indicators show mixed signals, suggesting potential difficulties ahead.
Read More





